2024-11-01 2025-10-31 false Capium Accounts Production 1.1 12925849 2024-11-01 2025-10-31 12925849 bus:AbridgedAccounts 2024-11-01 2025-10-31 12925849 bus:FRS102 2024-11-01 2025-10-31 12925849 bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 12925849 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 12925849 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 12925849 2024-11-01 2025-10-31 12925849 2025-10-31 12925849 bus:RegisteredOffice 2024-11-01 2025-10-31 12925849 core:WithinOneYear 2025-10-31 12925849 core:AfterOneYear 2025-10-31 12925849 1 2024-11-01 2025-10-31 12925849 bus:Director1 2024-11-01 2025-10-31 12925849 bus:Director1 2025-10-31 12925849 bus:Director1 2023-11-01 2024-10-31 12925849 2023-11-01 12925849 bus:LeadAgentIfApplicable 2024-11-01 2025-10-31 12925849 2023-11-01 2024-10-31 12925849 2024-10-31 12925849 core:WithinOneYear 2024-10-31 12925849 core:AfterOneYear 2024-10-31 12925849 bus:EntityAccountantsOrAuditors 2023-11-01 2024-10-31 12925849 bus:OrdinaryShareClass1 2024-11-01 2025-10-31 12925849 bus:OrdinaryShareClass1 2025-10-31 12925849 bus:OrdinaryShareClass1 2023-11-01 2024-10-31 12925849 bus:OrdinaryShareClass1 2024-10-31 12925849 core:PlantMachinery 2024-11-01 2025-10-31 12925849 core:PlantMachinery 2025-10-31 12925849 core:PlantMachinery 2024-10-31 12925849 core:FurnitureFittings 2024-11-01 2025-10-31 12925849 core:FurnitureFittings 2025-10-31 12925849 core:FurnitureFittings 2024-10-31 12925849 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-10-31 12925849 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-10-31 12925849 core:CostValuation core:Non-currentFinancialInstruments 2025-10-31 12925849 core:CostValuation core:Non-currentFinancialInstruments 2024-10-31 12925849 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-10-31 12925849 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 12925849 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-10-31 12925849 core:Non-currentFinancialInstruments 2025-10-31 12925849 core:Non-currentFinancialInstruments 2024-10-31 12925849 core:ShareCapital 2025-10-31 12925849 core:ShareCapital 2024-10-31 12925849 core:RetainedEarningsAccumulatedLosses 2025-10-31 12925849 core:RetainedEarningsAccumulatedLosses 2024-10-31 12925849 dpl:Item1 2024-11-01 12925849 dpl:Item1 2025-10-31 12925849 dpl:Item1 2023-11-01 12925849 dpl:Item1 2024-10-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12925849
England and Wales

 

 

 

EYE SURGEONS OF EDINBURGH LTD



Abridged Accounts
 


Period of accounts

Start date: 01 November 2024

End date: 31 October 2025
 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 3 379,156    299,675 
379,156    299,675 
Current assets      
Debtors 250,000    250,000 
Cash at bank and in hand 763,687    533,860 
1,013,687    783,860 
Creditors: amount falling due within one year (642,550)   (515,662)
Net current assets 371,137    268,198 
 
Total assets less current liabilities 750,293    567,873 
Net assets 750,293    567,873 
 

Capital and reserves
     
Called up share capital 4 100    100 
Profit and loss account 750,193    567,773 
Shareholders' funds 750,293    567,873 
 


For the year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 07 July 2026 and were signed by:


-------------------------------
Manjit Singh Mehat
Director
1
General Information
Eye Surgeons of Edinburgh Ltd is a private company, limited by shares, registered in England and Wales, registration number 12925849, registration address 110 Carlton Avenue East, Wembley, Middlesex, HA9 8LY.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 25% Reducing Balance
Fixtures and Fittings 25% Reducing Balance
2.

Average number of employees

Average number of employees during the year was 0 (2024 : 0).
3.

Tangible fixed assets

Cost or valuation Plant and Machinery   Fixtures and Fittings   Total
  £   £   £
At 01 November 2024 15,150    284,525    299,675 
Additions 154,650    51,215    205,865 
Disposals    
At 31 October 2025 169,800    335,740    505,540 
Depreciation
At 01 November 2024    
Charge for year 42,450    83,934    126,384 
On disposals    
At 31 October 2025 42,450    83,934    126,384 
Net book values
Closing balance as at 31 October 2025 127,350    251,806    379,156 
Opening balance as at 01 November 2024 15,150    284,525    299,675 


4.

Share Capital

Allotted, called up and fully paid
2025
£
  2024
£
100 Class A shares of £1.00 each 100    100 
100    100 

2